As the worldwide population rapidly ages, the global burden of age-related neurodegenerative diseases is expected to increase greatly in the next decade. Despite the challenges presented by these complex diseases, we have many reasons for hope. Critical discoveries into underlying disease biology and mechanisms, integration of AI and computational tool use into the field, and gene-based medical advances are ushering in a new era of diagnostic tools and therapeutic developments. Philanthropists are working at multiple scales across the science and health ecosystem to stimulate public attention and the financial support essential to achieve critical breakthroughs in managing neurodegenerative diseases. Now is the time for big investments and bold action to ensure that an increased health span is available to everyone. 

Moderator

Emily Baxi

Director, SPARC: Science Philanthropy Accelerator for Research and Collaboration, Milken Institute

Speakers

Patrick Brannelly

CEO, The 10,000 Brains Project

Kristin Holloway

Board of Directors, Association for Frontotemporal Degeneration

Ali Rezai

Executive Chair, Rockefeller Neuroscience Institute, West Virginia University

Ari Simon

President, Tambourine Philanthropies